08:00-08:45
- Satellite Symposium 3
- 54
- Venue: Room 1 (Vista 1+2)
54
09:00-10:15
- Special Session:
- GBCC’s Outstanding Oral Presentation 134
- Venue: Room 1 (Vista 1+2)
34
- Panel Discussion 4:
- Integrative Approaches in Local Control for Breast Cancer19
- Venue: Room 2 (Grand 1)
19
- Symposium 7:
- Salvage Treatment for Locoregional Recurrence7
- Venue: Room 3 (Walker 1)
7
- Nursing Session 1 (Kor.):
- Comprehensive Patient Care for ABC Patients Treated with Radiotherapy43
- Venue: Room 4 (Walker 2)
43
- GBCC-TBCS Joint Session:
- Breast Cancer Research in Two Technology Powerhouses: Korea and Taiwan45
- Venue: Room 5 (Art Hall)
45
10:30-11:45
- Special Session:
- GBCC’s Outstanding Oral Presentation 235
- Venue: Room 1 (Vista 1+2)
35
- Panel Discussion 5:
- Collaborative Strategies for Brain Metastases in Breast Cancer20
- Venue: Room 2 (Grand 1)
20
- Education Session 3:
- Optimal Surgical Treatment for Early to Advanced BC24
- Venue: Room 3 (Walker 1)
24
- Nursing Session 2 (Kor.):
- Motherhood in Breast Cancer Survivor: Challenges and Opportunities44
- Venue: Room 4 (Walker 2)
44
- GBCC-JBCS Joint Session:
- JAPAN-KOREA Breast Cancer Research International Dialogue for Global Excellence (J-K BRIDGE)46
- Venue: Room 5 (Art Hall)
46
12:00-12:45
- Plenary Lecture 3:
- Management of the Axilla in Patients Treated with Neoadjuvant Chemotherapy13
- Venue: Room 1 (Vista 1+2)
13
13:00-13:45
- Satellite Symposium 4
- 55
- Venue: Room 1 (Vista 1+2)
55
- Satellite Symposium 5
- 56
- Venue: Room 2 (Grand 1)
56
14:00-14:45
- Plenary Lecture 4:
- Tracking Triple Negative Breast Cancer Evolution and Immune Evasion: Insights from TRACERx14
- Venue: Room 1 (Vista 1+2)
14
15:00-15:50
- Junior Doctors Forum
- 50
- Venue: Room 4 (Walker 2)
50
15:00-16:15
- Symposium 8:
- From Neoadjuvant to Adjuvant: Optimizing Post Neoadjuvant Systemic Therapy9
- Venue: Room 1 (Vista 1+2)
9
- Panel Discussion 6:
- How Deep Impact of gBRCA1/2 Sequencing21
- Venue: Room 2 (Grand 1)
21
- Education Session 4:
- Antibody-Drug Conjugates in Clinical Practice: Bridging Innovation and Real-World Application25
- Venue: Room 3 (Walker 1)
25
- GBCC-SSO Joint Session:
- Treatment Strategies for Low-risk Ductal Carcinoma in Situ48
- Venue: Room 5 (Art Hall)
48
16:05-17:45
- Junior Doctors Debate
- 51
- Venue: Room 4 (Walker 2)
51
16:30-17:45
- Symposium 9:
- From Genomics to Biomarker10
- Venue: Room 1 (Vista 1+2)
10
- Special Session:
- Clinical Controversy Session: Omission of SLNB in Early Breast Cancer33
- Venue: Room 2 (Grand 1)
33
- Education Session 5:
- Breast Reconstruction and RT26
- Venue: Room 3 (Walker 1)
26
- GBCC-CACA Joint Session:
- New Developments in Systemic Management for High-Risk Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer47
- Venue: Room 5 (Art Hall)
47